Ken Kengatharan
A biotech executive with significant experience in successfully setting-up, securing capital, and growing multiple companies each starting from an idea. My major focus is to enable the translation of multiple innovative ideas around biology, tech, and engineering into solution-based transformative therapies that benefit patients.
Interests: Orphan drugs & rare diseases (and use of Tx, TxDx, Digital Tx, TxFood, Med. devices, Gene Tx >2.0), distributed ledger technology v1 to v(n>1) (blockchain, DAG), AI/ML, hIoT, innovative ways to structure and fund high growth companies in healthcare (both private and public).
Interests: Orphan drugs & rare diseases (and use of Tx, TxDx, Digital Tx, TxFood, Med. devices, Gene Tx >2.0), distributed ledger technology v1 to v(n>1) (blockchain, DAG), AI/ML, hIoT, innovative ways to structure and fund high growth companies in healthcare (both private and public).
Country:
USA